Viridian Therapeutics (NASDAQ:VRDN) Earnings Information
Viridian Therapeutics last released its quarterly earnings data on March 24th, 2021. The reported ($5.31) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.27) by $4.04. Viridian Therapeutics has generated $0.00 earnings per share over the last year. Viridian Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 6th, 2021 based off prior year's report dates.
Viridian Therapeutics Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Viridian Therapeutics (NASDAQ VRDN) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)